Kalvista Pharmaceuticals
$27.00
36
+$0.01+0.04% Wednesday 20:00
-$0.01-0.04%Wednesday 22:10Pre-market
Statistics
Day High
27
Day Low
26.98
52W High
27
52W Low
9.83
Volume
4,262,878
Avg. Volume
3,503,564
Mkt Cap
1.36B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3SepExpected
Expected EPS
-0.37625
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-366.89MNet Income
Analyst Ratings
32.33Average Price Target
The highest estimate is 42.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 25%
Hold 75%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KALV. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap38.9B
Vertex Pharmaceuticals
VRTX
Mkt Cap124.7B
Regeneron Pharmaceuticals
REGN
Mkt Cap66.35B
Biogen
BIIB
Mkt Cap31.89B
AMGEN
AMGN
Mkt Cap193.39B
Novartis
NVS
Mkt Cap296.54B
Gilead Sciences
GILD
Mkt Cap158.77B
Abbvie
ABBV
Mkt Cap447.62B
About
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.
Show more...
CEO
Mr. Benjamin L. Palleiko
Employees
275
Country
United States
ISIN
US4834971032
Listings
0 Comments
Share your thoughts
FAQ
What is Kalvista Pharmaceuticals stock price today?▼
The current price of KALV is $27.00 USD — it has increased by +0.04% in the past 24 hours. Watch Kalvista Pharmaceuticals stock price performance more closely on the chart.
What is Kalvista Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kalvista Pharmaceuticals stocks are traded under the ticker KALV.
Is Kalvista Pharmaceuticals stock price growing?▼
KALV stock has risen by +0% compared to the previous week, the month change is a +0.19% rise, over the last year Kalvista Pharmaceuticals has showed a +124.25% increase.
What is Kalvista Pharmaceuticals market cap?▼
Today Kalvista Pharmaceuticals has the market capitalization of 1.36B
When is the next Kalvista Pharmaceuticals earnings date?▼
Kalvista Pharmaceuticals is going to release the next earnings report on September 03, 2026.
What were Kalvista Pharmaceuticals earnings last quarter?▼
KALV earnings for the last quarter are -0.43 USD per share, whereas the estimation was -0.38 USD resulting in a -13.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kalvista Pharmaceuticals revenue for the last year?▼
Kalvista Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Kalvista Pharmaceuticals net income for the last year?▼
KALV net income for the last year is -366.89M USD.
How many employees does Kalvista Pharmaceuticals have?▼
As of July 06, 2026, the company has 275 employees.
In which sector is Kalvista Pharmaceuticals located?▼
Kalvista Pharmaceuticals operates in the Health & Wellness sector.
When did Kalvista Pharmaceuticals complete a stock split?▼
The last stock split for Kalvista Pharmaceuticals was on November 22, 2016 with a ratio of 1:14.
Where is Kalvista Pharmaceuticals headquartered?▼
Kalvista Pharmaceuticals is headquartered in Framingham, United States.